Results 131 to 140 of about 284,062 (202)

The FDA's plan to phase out animal testing. [PDF]

Trends Biotechnol
Gerke S, Balamut J, Wagner JK.
europepmc   +1 more source

Cytology at the crossroads: Safeguarding equity in the molecular era. [PDF]

Cytojournal
Díaz Del Arco C.
europepmc   +1 more source

Alternatives in animal testing.

Environmental health perspectives, 1997
openaire   +1 more source

Ten Years and Still no Alternatives to Animal Testing [PDF]

Journal of Toxicology: Cutaneous and Ocular Toxicology, 1993
openaire   +1 more source

Alternative methods for developmental toxicity testing: features, status and future directions. [PDF]

J Vet Sci
Hwang I, Jeung EB.
europepmc   +1 more source

Integrating New Approach Methodologies (NAMs) into Preclinical Regulatory Evaluation of Oncology Drugs. [PDF]

Biomimetics (Basel)
Mirlohi MS, Yousefi T, Aref AR, Seyfoori A.   +3 more
europepmc   +1 more source

AI-Enabled Reduction of Animal Use in Cardiovascular Translational Medicine: Regulatory and Technological Perspectives. [PDF]

Life (Basel)
Dinc R, Ardic N.
europepmc   +1 more source

New approach methodologies (NAMs) to support regulatory assessment of developmental immunotoxicity - a new PARC project. [PDF]

Front Toxicol
Smith NM, de Bruijn VMP, Vandebriel RJ, Hargitai R, Lumniczky K, Janssen AWF, Beekmann K, Usta B, Tigges J, Spruck C, Hurem S, Iulini M, Corsini E, Bado-Nilles A, Beaudouin R, Katsiadaki I, Cano I, Sebire M, Ayuk HS, Stojanovska V, Zenclussen AC, Blanc EB, Kerdine-Römer S, Lacerda R, Romão L, Monfort-Lanzas P, Gostner JM, Mposhi A, Turner JD, Del Favero G, Lindeman B.   +30 more
europepmc   +1 more source

Artificial intelligence-, organoid-, and organ-on-chip-powered models to improve pre-clinical animal testing of vaccines and immunotherapeutics: potential, progress, and challenges. [PDF]

Front Artif Intell
Elfatimi E, Lekbach Y, Prakash S, Karan S, Dorotta JC, Garcia A, Suoth BS, Maurya C, Omorogieva EY, Ng SXL, Liao EJ, Chow RA, BenMohamed L.   +12 more
europepmc   +1 more source

The promise of cardiomyocyte computational models for drug safety. [PDF]

Mil Med Res
Wang L, Rodriguez B.
europepmc   +1 more source